Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRSNASDAQ:SERANASDAQ:TOINASDAQ:VMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$4.42+1.6%$2.61$1.53▼$9.20$259.81M1.95216,129 shs448,652 shsSERASera Prognostics$1.64-0.6%$2.94$1.63▼$9.91$61.78M0.99137,444 shs278,215 shsTOIOncology Institute$3.21+2.9%$2.25$0.13▼$3.50$242.54M0.04932,636 shs1.77 million shsVMDViemed Healthcare$6.57$6.83$6.14▼$9.81$259.67M1.49139,911 shs78,002 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies-2.25%+11.25%+106.16%-2.68%0.00%SERASera Prognostics-1.79%-14.06%-45.00%-59.76%-80.84%TOIOncology Institute+3.65%+16.85%+7.22%+250.52%+551.36%VMDViemed Healthcare-0.45%-1.50%-7.07%-16.52%-7.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIRSAirSculpt Technologies0.6593 of 5 stars1.00.00.00.02.65.00.0SERASera Prognostics0.9173 of 5 stars0.02.00.00.02.72.50.6TOIOncology Institute1.937 of 5 stars3.53.00.00.01.51.70.0VMDViemed Healthcare1.3226 of 5 stars0.03.00.00.03.22.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 2.00Hold$3.75-15.16% DownsideSERASera Prognostics 0.00N/AN/AN/ATOIOncology Institute 3.00Buy$7.00118.07% UpsideVMDViemed Healthcare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SERA, VMD, AIRS, and TOI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025TOIOncology InstituteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$7.003/31/2025AIRSAirSculpt TechnologiesLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $2.50(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$172.10M1.51$0.18 per share25.15$1.46 per share3.03SERASera Prognostics$115K537.25N/AN/A$2.21 per share0.74TOIOncology Institute$403.15M0.60N/AN/A$0.77 per share4.17VMDViemed Healthcare$232.79M1.12$0.69 per share9.56$2.96 per share2.22Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$4.48M-$0.30N/A∞N/A-4.13%2.22%0.90%8/8/2025 (Estimated)SERASera Prognostics-$36.24M-$0.94N/AN/AN/AN/A-51.73%-36.94%8/6/2025 (Estimated)TOIOncology Institute-$83.07M-$0.70N/A∞N/A-17.63%-186.83%-34.58%8/11/2025 (Estimated)VMDViemed Healthcare$10.24M$0.3024.33∞N/A4.87%8.72%6.48%8/5/2025 (Estimated)Latest SERA, VMD, AIRS, and TOI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025SERASera Prognostics-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 million5/14/2025Q1 2025TOIOncology InstituteN/A-$0.18N/A-$0.21N/A$104.41 million5/7/2025Q1 2025VMDViemed Healthcare$0.06$0.06N/A$0.06$60.60 million$59.10 million3/24/2025Q4 2024TOIOncology Institute-$0.08-$0.14-$0.06-$0.14$109.15 million$100.27 million3/19/2025Q4 2024SERASera Prognostics-$0.23-$0.25-$0.02-$0.25$0.01 million$0.02 million3/14/2025Q4 2024AIRSAirSculpt Technologies-$0.03-$0.08-$0.05-$0.09$38.99 million$39.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.800.510.51SERASera PrognosticsN/A2.112.11TOIOncology Institute5.912.492.27VMDViemed Healthcare0.031.311.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%SERASera Prognostics54.64%TOIOncology Institute36.86%VMDViemed Healthcare74.24%Insider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies76.58%SERASera Prognostics13.50%TOIOncology Institute8.50%VMDViemed Healthcare20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24058.78 million12.56 millionOptionableSERASera Prognostics12037.67 million28.44 millionOptionableTOIOncology Institute66075.56 million68.38 millionNot OptionableVMDViemed Healthcare63039.52 million31.15 millionNot OptionableSERA, VMD, AIRS, and TOI HeadlinesRecent News About These CompaniesBNP Paribas Financial Markets Invests $378,000 in Viemed Healthcare, Inc. (NASDAQ:VMD)May 27 at 3:14 AM | marketbeat.comParadigm Capital Management Inc. NY Decreases Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)May 22, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes Position in Viemed Healthcare, Inc. (NASDAQ:VMD)May 19, 2025 | marketbeat.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMay 14, 2025 | finance.yahoo.comExpect Equity LLC Takes $1.37 Million Position in Viemed Healthcare, Inc. (NASDAQ:VMD)May 11, 2025 | marketbeat.comViemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comLake Street Keeps Their Buy Rating on Viemed Healthcare (VMD)May 9, 2025 | theglobeandmail.comViemed Healthcare Inc (VMD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...May 9, 2025 | finance.yahoo.comDivisadero Street Capital Management LP Has $5.18 Million Stake in Viemed Healthcare, Inc. (NASDAQ:VMD)May 9, 2025 | marketbeat.comViemed Healthcare, Inc. Announces Definitive Agreement to Acquire Lehan's Medical EquipmentMay 8, 2025 | nasdaq.comViemed Healthcare, Inc. Reports Q1 2025 Financial Results and Updates Full Year GuidanceMay 7, 2025 | quiverquant.comViemed Healthcare Announces First Quarter 2025 Financial ResultsMay 7, 2025 | globenewswire.comViemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in IllinoisMay 6, 2025 | globenewswire.comApis Capital Advisors LLC Acquires 35,200 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)May 5, 2025 | marketbeat.comViemed Healthcare, Inc. (NASDAQ:VMD) Short Interest UpdateMay 5, 2025 | marketbeat.comNantahala Capital Management LLC Sells 200,000 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)April 30, 2025 | marketbeat.comViemed Healthcare Announces First Quarter 2025 Earnings Conference Call DetailsApril 22, 2025 | globenewswire.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMarch 28, 2025 | insidermonkey.comViemed stays ‘nimble’March 15, 2025 | hmenews.comIn Lafayette, health care jobs continue to rise. VieMed is a key reason why.March 13, 2025 | theadvocate.comViemed Healthcare, Inc. (VMD) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSERA, VMD, AIRS, and TOI Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$4.42 +0.07 (+1.61%) Closing price 04:00 PM EasternExtended Trading$4.38 -0.04 (-1.02%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.Sera Prognostics NASDAQ:SERA$1.64 -0.01 (-0.61%) Closing price 04:00 PM EasternExtended Trading$1.64 0.00 (0.00%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.Oncology Institute NASDAQ:TOI$3.21 +0.09 (+2.88%) Closing price 04:00 PM EasternExtended Trading$3.18 -0.02 (-0.78%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.Viemed Healthcare NASDAQ:VMD$6.57 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$6.58 +0.00 (+0.08%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
